Testosterone Science

FDA, Regulation and Guidelines

US Aims for a ‘High-T’ Military. Pentagon to Annually Screen Troops Aged 30 & Above for Testosterone

Specific Claim Evaluated

Testosterone levels generally decline with age, but medical guidelines do not ordinarily recommend testing every man after a particular age.

Primary Research Supporting or Contradicting the Claim

In a population-based survey, 24% of men aged 30 to 79 years had total testosterone below 300 ng/dL, while the crude prevalence of symptomatic androgen deficiency was 5.6% (Araujo et al., 2007). Guidelines restrict diagnosis to men with symptoms and confirmed low levels (Bhasin et al., 2018).

Corrected Evidence-Based Interpretation

Accurate.

Rationale for Grade

The article supplies the guideline context that is missing from some other coverage of the same announcement. Its statements on age-related decline and testing practice are consistent with population and guideline data. It reports official statements with attribution.

References

  1. Araujo AB, Esche GR, Kupelian V, O'Donnell AB, Travison TG, Williams RE, Clark RV, McKinlay JB. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab. 2007;92(11):4241-4247. PMID
    Supporting excerpt: "Crude prevalence of symptomatic androgen deficiency was 5.6%"
  2. Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, Snyder PJ, Swerdloff RS, Wu FC, Yialamas MA. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. PMID
    Supporting excerpt: "We recommend making a diagnosis of hypogonadism only in men with symptoms and signs"

Post a Comment

Shared Decision Making

Bring the Evidence to Your Next Consultation

Use our patient resources and questionnaires to prepare questions about symptoms, testing and treatment options for your doctor.